Genetic
taking blood samples
taking blood samples is a genetic therapy with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
GENETIC
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(1)
Other(2)
Detailed Status
unknown2
Completed1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed125%
unknown250%
withdrawn125%
Recent Activity
0 active trials
Showing 4 of 4
unknown
Telomeric Abnormalities in Colorectal Diseases by Fluorescent in Situ Hybridization Technique
NCT03208777
withdrawn
Performance of CAST (Cellular Antigen Stimulation Test) in Patients With Wasp Venom Allergy: Evaluation of Neutralizing IgG Subclasses
NCT00794287
completednot_applicable
Validation of Non-invasive Hemoglobin (SpHb) Measurement in Children
NCT01693016
unknownnot_applicable
A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery
NCT01393587
Clinical Trials (4)
Showing 4 of 4 trials
NCT03208777
Telomeric Abnormalities in Colorectal Diseases by Fluorescent in Situ Hybridization Technique
NCT00794287
Performance of CAST (Cellular Antigen Stimulation Test) in Patients With Wasp Venom Allergy: Evaluation of Neutralizing IgG Subclasses
NCT01693016Not Applicable
Validation of Non-invasive Hemoglobin (SpHb) Measurement in Children
NCT01393587Not Applicable
A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery
All 4 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 4